SCHEMBL23310406

SCHEMBL23310406

ON(O)c1cccc2c1oc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.50
▸ MAOA P21397 4/20 0.43
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ AHR P35869 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ LIMK1 P53667 1/20 0.39
▸ KDM5A P29375 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ PGAM1 P18669 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6372657 0.84 ALOX5 (0.45) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL25061152 0.81 ALOX5 (0.43) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL19929766 0.81 ALOX5 (0.43) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL14295465 0.79 ALOX5 (0.42) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL15178580 0.78 ALOX5 (0.41) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL23046767 0.78 ALOX5 (0.44) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL15306316 0.78 ALOX5 (0.41) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL22857649 0.78 ALOX5 (0.41) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL23056753 0.77 ALOX5 (0.40) ALOX5MAOAMEN1KMT2ACYP2C19
SCHEMBL20887131 0.77 ALOX5 (0.43) ALOX5MAOAMEN1KMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
US-20210122774-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122774-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND L1CAM, NOM1, MSL1 ALOX5 3368/4885MAOA 2570/4885MEN1 4/4885
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND ALOX5 354/4885MAOA 194/4885MEN1 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback